Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 14463-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#14463-1-AP, RRID:AB_2158952
- Product name
- PARVB antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated PARVB antibody (Cat. #14463-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references TET2-mediated ECM1 hypomethylation promotes the neovascularization in active proliferative diabetic retinopathy.
Inhibition of the ILK-AKT pathway by upregulation of PARVB contributes to the cochlear cell death in Fascin2 gene knockout mice.
Disruption of the integrin-linked kinase (ILK) pseudokinase domain affects kidney development in mice.
DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25.
Integrin-Linked Kinase Mediates Therapeutic Resistance of Quiescent CML Stem Cells to Tyrosine Kinase Inhibitors.
The Integrin-Mediated ILK-Parvin-αPix Signaling Axis Controls Differentiation in Mammary Epithelial Cells.
Integrin-linked kinase links dynactin-1/dynactin-2 with cortical integrin receptors to orient the mitotic spindle relative to the substratum.
A critical role of integrin-linked kinase, ch-TOG and TACC3 in centrosome clustering in cancer cells.
Cai C, Gu C, He S, Meng C, Lai D, Zhang J, Qiu Q
Clinical epigenetics 2024 Jan 3;16(1):6
Clinical epigenetics 2024 Jan 3;16(1):6
Inhibition of the ILK-AKT pathway by upregulation of PARVB contributes to the cochlear cell death in Fascin2 gene knockout mice.
Liu R, Shang W, Liu Y, Xie Y, Luan J, Zhang T, Ma Y, Wang Z, Sun Y, Song X, Han F
Cell death discovery 2024 Feb 19;10(1):89
Cell death discovery 2024 Feb 19;10(1):89
Disruption of the integrin-linked kinase (ILK) pseudokinase domain affects kidney development in mice.
Bulus N, Brown KL, Mernaugh G, Böttcher A, Dong X, Sanders CR, Pozzi A, Fässler R, Zent R
The Journal of biological chemistry 2021 Jan-Jun;296:100361
The Journal of biological chemistry 2021 Jan-Jun;296:100361
DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25.
Yang L, Liu Q, Zhang X, Liu X, Zhou B, Chen J, Huang D, Li J, Li H, Chen F, Liu J, Xing Y, Chen X, Su S, Song E
Nature 2020 Jul;583(7814):133-138
Nature 2020 Jul;583(7814):133-138
Integrin-Linked Kinase Mediates Therapeutic Resistance of Quiescent CML Stem Cells to Tyrosine Kinase Inhibitors.
Rothe K, Babaian A, Nakamichi N, Chen M, Chafe SC, Watanabe A, Forrest DL, Mager DL, Eaves CJ, Dedhar S, Jiang X
Cell stem cell 2020 Jul 2;27(1):110-124.e9
Cell stem cell 2020 Jul 2;27(1):110-124.e9
The Integrin-Mediated ILK-Parvin-αPix Signaling Axis Controls Differentiation in Mammary Epithelial Cells.
Rooney N, Wang P, Brennan K, Gilmore AP, Streuli CH
Journal of cellular physiology 2016 Nov;231(11):2408-17
Journal of cellular physiology 2016 Nov;231(11):2408-17
Integrin-linked kinase links dynactin-1/dynactin-2 with cortical integrin receptors to orient the mitotic spindle relative to the substratum.
Morris EJ, Assi K, Salh B, Dedhar S
Scientific reports 2015 Feb 11;5:8389
Scientific reports 2015 Feb 11;5:8389
A critical role of integrin-linked kinase, ch-TOG and TACC3 in centrosome clustering in cancer cells.
Fielding AB, Lim S, Montgomery K, Dobreva I, Dedhar S
Oncogene 2011 Feb 3;30(5):521-34
Oncogene 2011 Feb 3;30(5):521-34
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The PARVB antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human PARVB. This antibody recognizes human, mouse, rat antigen. The PARVB antibody has been validated for the following applications: ELISA, WB analysis.
